The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; Bayer; BMS; Ipsen; Janssen Oncology; Johnson & Johnson/Janssen; Pfizer
Research Funding - Bayer (Inst); Janssen (Inst); Sanofi (Inst)
 
Consulting or Advisory Role - Bayer; Regeneron
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Ipsen; Pfizer
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer
The Bristol Bladder Trial: Five year outcomes in patients treated with neoadjuvant cabazitaxel and cisplatin chemotherapy for muscle invasive transitional cell carcinoma of the urinary bladder.
 
Amarnath Challapalli
No Relationships to Disclose
 
Paul White
No Relationships to Disclose
 
Susan Masson
No Relationships to Disclose
 
Emily Foulstone
Research Funding - Janssen (Inst); Sanofi (Inst)
 
Emily Renninson
Research Funding - Janssen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen
 
Alicia Bravo
Research Funding - Janssen (Inst); Sanofi (Inst)
 
Sylvia Pearson
No Relationships to Disclose
 
Narges Dailami
No Relationships to Disclose
 
Raj Persad
No Relationships to Disclose
 
Anthony Koupparis
No Relationships to Disclose
 
Edward Rowe
No Relationships to Disclose
 
Jon Oxley
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca
 
Julian Kabala
No Relationships to Disclose
 
Janice Ash-Miles
No Relationships to Disclose
 
Amit Bahl
No Relationships to Disclose